IGC Pharma, Inc. (IGC)
0.2901
+0.01
(+4.02%)
USD |
NYAM |
Feb 25, 16:00
0.281
-0.01
(-3.14%)
After-Hours: 06:18
IGC Pharma Free Cash Flow : -6.262M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| ACADIA Pharmaceuticals, Inc. | 98.97M |
| Agenus, Inc. | -89.31M |
| Alnylam Pharmaceuticals, Inc. | 465.38M |
| Savara, Inc. | -99.27M |
| Arrowhead Pharmaceuticals, Inc. | 327.01M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -2.09M |
| Cash from Investing (Quarterly) | -0.374M |
| Cash from Financing (Quarterly) | 3.11M |
| Free Cash Flow Per Share (Quarterly) | -0.0267 |
| Free Cash Flow to Equity (Quarterly) | -2.361M |
| Free Cash Flow to Firm (Quarterly) | -2.416M |
| Free Cash Flow Yield | -26.01% |